RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness

Keyphrases

• Adverse Outcomes 100%
• Response-outcome 100%
• Critical Illness 100%
• Toll-like Receptor 4 (TLR4) 100%
• Retinoic 100%
• Pediatric Influenza 100%
• TLR4 Signaling Pathway 60%
• Production Capacity 40%
• Hospitalization 20%
• Toll-like 20%
• Clinical Outcomes 20%
• Prospective Observational Study 20%
• Antiviral Response 20%
• Risk Stratification 20%
• Whole Blood 20%
• Influenza-like Illness 20%
• Bacterial Infection 20%
• Low Molecular Weight 20%
• Polyinosinic-polycytidylic Acid 20%
• Immune Signaling 20%
• Increased Mortality 20%
• Influenza 20%
• Immune Monitoring 20%
• Multiple Organ Dysfunction Syndrome 20%
• Organ Dysfunction 20%
• Intensive Care Unit Admission 20%
• LPS Stimulation 20%
• Antiviral Immune Response 20%
• Ventilation Rate 20%
• Whole Blood Stimulation 20%
• Acute Hypoxemic Respiratory Failure 20%
• Immunocompetent child 20%
• Viral Ligands 20%
• Severe Influenza 20%
• Antibacterial Response 20%

Medicine and Dentistry

• Pediatrics 100%
• Adverse Outcome 100%
• Toll Like Receptor 4 100%
• Critical Illness 100%
• Tumor Necrosis Factor 50%
• Antivirus Agent 50%
• Ex Vivo 33%
• Signal Transduction 33%
• Influenza 33%
• Polyinosinic Polycytidylic Acid 16%
• Cohort Study 16%
• Artificial Respiration 16%
• Antiinfective Agent 16%
• Intensive Care Unit 16%
• Respiratory Failure 16%
• Risk Stratification 16%
• Mixed Infection 16%
• Multiple Organ Dysfunction Syndrome 16%